AAAAAA

   
Results: 1-25 | 26-50 | 51-75
Results: 1-25/75
CHOLESTANOL AND SURVIVAL WITH SIMVASTATIN - MORE DATA ARE NEEDED
Authors: WALLIS EJ WILLIAMSON R RAMSAY LE YEO WW JACKSON PR
Citation: Ej. Wallis et al., CHOLESTANOL AND SURVIVAL WITH SIMVASTATIN - MORE DATA ARE NEEDED, BMJ. British medical journal, 317(7167), 1998, pp. 1252-1252
USE OF STATINS - SHEFFIELD TABLE IS USEFUL
Authors: RAMSAY LE WALLIS EJ HAQ IU WILLIAMSON R YEO WW JACKSON PR
Citation: Le. Ramsay et al., USE OF STATINS - SHEFFIELD TABLE IS USEFUL, BMJ. British medical journal, 317(7156), 1998, pp. 473-474
OILY FISH AND FISH-OIL SUPPLEMENTS IN THE PREVENTION OF CORONARY HEART-DISEASE
Authors: MINNIS RC HAQ IU JACKSON PR YEO WW RAMSAY LE
Citation: Rc. Minnis et al., OILY FISH AND FISH-OIL SUPPLEMENTS IN THE PREVENTION OF CORONARY HEART-DISEASE, Journal of human nutrition and dietetics, 11(1), 1998, pp. 13-19
THE RATIONALE FOR DIFFERING NATIONAL RECOMMENDATIONS FOR THE TREATMENT OF HYPERTENSION
Authors: RAMSAY LE WALLIS EJ YEO WM JACKSON PR
Citation: Le. Ramsay et al., THE RATIONALE FOR DIFFERING NATIONAL RECOMMENDATIONS FOR THE TREATMENT OF HYPERTENSION, American journal of hypertension, 11(6), 1998, pp. 79-88
GENETICALLY MEDIATED VARIATION IN ANGIOTENSIN-CONVERTING ENZYME EXPRESSION AND VASCULAR REACTIVITY IN HUMAN RESISTANCE VESSELS
Authors: OTOOLE L CHADWICK IG YEO WW JACKSON PR RAMSAY LE MORICE AH CHANNER KS
Citation: L. Otoole et al., GENETICALLY MEDIATED VARIATION IN ANGIOTENSIN-CONVERTING ENZYME EXPRESSION AND VASCULAR REACTIVITY IN HUMAN RESISTANCE VESSELS, Journal of the American College of Cardiology, 31(2), 1998, pp. 462-462
A NEW REGIMEN FOR STARTING WARFARIN THERAPY IN OUT-PATIENTS
Authors: OATES A JACKSON PR AUSTIN CA CHANNER KS
Citation: A. Oates et al., A NEW REGIMEN FOR STARTING WARFARIN THERAPY IN OUT-PATIENTS, British journal of clinical pharmacology, 46(2), 1998, pp. 157-161
DOES WHITE-COAT EFFECT CONTRIBUTE TO TREATMENT RESISTANCE IN HYPERTENSION
Authors: DAVIES SJC GHAHRAMANI P PALMER RL HIPPISLEYCOX J JACKSON PR YEO WW RAMSAY LE
Citation: Sjc. Davies et al., DOES WHITE-COAT EFFECT CONTRIBUTE TO TREATMENT RESISTANCE IN HYPERTENSION, Journal of hypertension, 16, 1998, pp. 27073-27073
PANIC ATTACKS AND HYPERTENSION - A RELATION WITH ISCHEMIC-HEART-DISEASE
Authors: DAVIES SJC GHAHRAMANI P JACKSON PR YEO WW RAMSAY LE
Citation: Sjc. Davies et al., PANIC ATTACKS AND HYPERTENSION - A RELATION WITH ISCHEMIC-HEART-DISEASE, Journal of hypertension, 16, 1998, pp. 27100-27100
THE IMPACT OF AMBULATORY BLOOD-PRESSURE ON ESTIMATION OF CARDIOVASCULAR RISK IN MILD HYPERTENSION
Authors: JACKSON PR HAQ IU WALLIS EJ YEO WW RAMSAY LE
Citation: Pr. Jackson et al., THE IMPACT OF AMBULATORY BLOOD-PRESSURE ON ESTIMATION OF CARDIOVASCULAR RISK IN MILD HYPERTENSION, Journal of hypertension, 16, 1998, pp. 27105-27105
DOES CHOLESTEROL REDUCTION LOWER BLOOD-PRESSURE
Authors: WALLIS EJ HAQ IU MINNIS R PALMER R GHARAMANI P YEO W JACKSON PR RAMSAY LE
Citation: Ej. Wallis et al., DOES CHOLESTEROL REDUCTION LOWER BLOOD-PRESSURE, Hypertension, 32(4), 1998, pp. 1-1
SHEFFIELD CARDIOVASCULAR RISK PROGRAM FOR TARGETING STATIN TREATMENT - SCRIPTS FOR ROUTINE USE IN GENERAL-PRACTICE
Authors: GHAHRAMANI P HAQ IU YEO WW JACKSON PR RAMSAY LE
Citation: P. Ghahramani et al., SHEFFIELD CARDIOVASCULAR RISK PROGRAM FOR TARGETING STATIN TREATMENT - SCRIPTS FOR ROUTINE USE IN GENERAL-PRACTICE, Hypertension, 32(4), 1998, pp. 2-2
STATINS FOR PREVENTION OF STROKE
Authors: WALLIS EJ RAMSAY LE YEO WW JACKSON PR
Citation: Ej. Wallis et al., STATINS FOR PREVENTION OF STROKE, Lancet, 352(9131), 1998, pp. 909-910
DRUG-THERAPY FOR CORONARY HEART-DISEASE - THE SHEFFIELD TABLE
Authors: RAMSAY LE WALLIS EJ HAQ IU YEO WW JACKSON PR
Citation: Le. Ramsay et al., DRUG-THERAPY FOR CORONARY HEART-DISEASE - THE SHEFFIELD TABLE, Lancet, 351(9100), 1998, pp. 443-443
PROTEIN-BINDING OF ASPIRIN AND SALICYLATE MEASURED BY IN-VIVO ULTRAFILTRATION
Authors: GHAHRAMANI P ROWLANDYEO K YEO WW JACKSON PR RAMSAY LE
Citation: P. Ghahramani et al., PROTEIN-BINDING OF ASPIRIN AND SALICYLATE MEASURED BY IN-VIVO ULTRAFILTRATION, Clinical pharmacology and therapeutics, 63(3), 1998, pp. 285-295
EFFECT OF CYP2D6 GENETIC-POLYMORPHISM ON SIDE-EFFECTS OF AMITRIPTYLINE AND NORTRIPTYLINE
Authors: GHAHRAMANI P DAVIES SJC YEO WW JACKSON PR TUCKER GT RAMSAY LE
Citation: P. Ghahramani et al., EFFECT OF CYP2D6 GENETIC-POLYMORPHISM ON SIDE-EFFECTS OF AMITRIPTYLINE AND NORTRIPTYLINE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 51-51
USE OF STATINS - EVIDENCE ON EFFECTIVENESS IS STRONGER FOR STATINS THAN FOR OTHER TREATMENTS
Authors: WALLIS EJ RAMSAY LE YEO WW JACKSON PR PICKIN M HAQ IU
Citation: Ej. Wallis et al., USE OF STATINS - EVIDENCE ON EFFECTIVENESS IS STRONGER FOR STATINS THAN FOR OTHER TREATMENTS, BMJ. British medical journal, 315(7122), 1997, pp. 1618-1619
THE IMPACT OF TECHNOLOGY CHARACTERISTICS AND JOB CONTROL ON WORKER MENTAL-HEALTH
Authors: MULLARKEY S JACKSON PR WALL TD WILSON JR GREYTAYLOR SM
Citation: S. Mullarkey et al., THE IMPACT OF TECHNOLOGY CHARACTERISTICS AND JOB CONTROL ON WORKER MENTAL-HEALTH, Journal of organizational behavior, 18(5), 1997, pp. 471-489
PANIC DISORDER, ANXIETY AND DEPRESSION IN RESISTANT HYPERTENSION - A CASE-CONTROL STUDY
Authors: DAVIES SJC GHAHRAMANI P JACKSON PR HIPPISLEYCOX J YEO WW RAMSAY LE
Citation: Sjc. Davies et al., PANIC DISORDER, ANXIETY AND DEPRESSION IN RESISTANT HYPERTENSION - A CASE-CONTROL STUDY, Journal of hypertension, 15(10), 1997, pp. 1077-1082
TREATMENT OF UNCOMPLICATED MILD HYPERTENSION - REAPPRAISAL OF THE RISK-BASED APPROACH
Authors: HAQ IU HOUGH RE YEO WW JACKSON PR RAMSAY LE
Citation: Iu. Haq et al., TREATMENT OF UNCOMPLICATED MILD HYPERTENSION - REAPPRAISAL OF THE RISK-BASED APPROACH, Hypertension, 30(4), 1997, pp. 22-22
WHITE-COAT EFFECT IN RESISTANT AND NON-RESISTANT HYPERTENSION - A CASE-CONTROL STUDY
Authors: DAVIES SJC GHAHRAMANI P PALMER RL HIPPISLEYCOX J JACKSON PR YEO WW RAMSAY LE
Citation: Sjc. Davies et al., WHITE-COAT EFFECT IN RESISTANT AND NON-RESISTANT HYPERTENSION - A CASE-CONTROL STUDY, Hypertension, 30(4), 1997, pp. 60-60
PRESSOR AND HORMONAL RESPONSES TO ANGIOTENSIN-I INFUSION IN HEALTHY-SUBJECTS OF DIFFERENT ANGIOTENSIN-CONVERTING ENZYME GENOTYPES
Authors: CHADWICK IG OTOOLE L MORICE AH YEO WW JACKSON PR RAMSAY LE
Citation: Ig. Chadwick et al., PRESSOR AND HORMONAL RESPONSES TO ANGIOTENSIN-I INFUSION IN HEALTHY-SUBJECTS OF DIFFERENT ANGIOTENSIN-CONVERTING ENZYME GENOTYPES, Journal of cardiovascular pharmacology, 29(4), 1997, pp. 485-489
LIPID-LOWERING STRATEGIES FOR THE PREVENTION OF CORONARY HEART-DISEASE - REPLY
Authors: HAQ IU RAMSAY LE PICKIN DM YEO WW JACKSON PR PAYNE JN
Citation: Iu. Haq et al., LIPID-LOWERING STRATEGIES FOR THE PREVENTION OF CORONARY HEART-DISEASE - REPLY, Clinical science, 92(4), 1997, pp. 431-432
DRUG-THERAPY FOR CORONARY HEART-DISEASE - THE SHEFFIELD TABLE
Authors: WALLIS EJ RAMSAY LE JACKSON PR YEO WW WILLIAMSON R
Citation: Ej. Wallis et al., DRUG-THERAPY FOR CORONARY HEART-DISEASE - THE SHEFFIELD TABLE, Lancet, 350(9094), 1997, pp. 1852-1852
CHOLESTEROL AND PREVENTION OF CORONARY HEART-DISEASE
Authors: HAQ IU JACKSON PR YEO WW RAMSAY LE
Citation: Iu. Haq et al., CHOLESTEROL AND PREVENTION OF CORONARY HEART-DISEASE, Lancet, 349(9046), 1997, pp. 210-211
CROSS-OVER TRIALS - A COMMENTARY
Authors: JACKSON PR YEO WW
Citation: Pr. Jackson et Ww. Yeo, CROSS-OVER TRIALS - A COMMENTARY, European Journal of Clinical Pharmacology, 52(2), 1997, pp. 155-156
Risultati: 1-25 | 26-50 | 51-75